logo-loader
Proactive logo live
magnificent seven
Big caps
Big tech outperformance coming to an end, says broker

Big Tech firms are likely coming to the end of a trend in which they outperform market...

20 minutes ago
Mid caps

bluebird bio set to outperform pessimistic expectations – broker

bluebird bio Inc (NASDAQ:BLUE), the gene therapy developer, is well-positioned to outperform...

17 hours, 38 minutes ago
Big caps

Disney able to increase shareholder returns, says broker

Walt Disney Co (NYSE:DIS, ETR:WDP) will be able to ramp up its buyback programs, grow its...

19 hours, 16 minutes ago
Insight

Xalles Holdings nurtures technology innovations for lucrative exits

"Management is doing things right; leadership is doing the right things." Famed business...

21 hours, 13 minutes ago
Big caps

Merck shares move higher as lung disorder drug secures ‘squeaky clean’ label...

Merck & Co Inc (NYSE:MRK, ETR:6MK) shares traded more than 4% higher after it won US Food...

22 hours, 2 minutes ago
Psychedelics

Psychedelics stocks fly as FDA recognizes Mind Medicine's LSD drug as...

Psychedelics stocks traded higher on Thursday as investor optimism returned to the sector on the...

3 weeks ago
Insight

Nevis Brands CEO talks opportunity for THC beverage Major in California...

Nevis Brands (CSE:NEVI)' cannabis beverage product Major is now available for purchase in...

1 month ago
Artificial Intelligence

1606 Corp sees growth through strategic partnerships in March

1606 Corp. (OTC:CBDW) said in March it plans to focus on growth through strategic partnerships...

1 month ago
Small caps

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth’s...

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB,...

1 month, 1 day ago

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 28 minutes ago

Join Proactive

Get ahead of the curve